A new analysis, published in The Lancet, includes 99 patients with laboratory-confirmed 2019 novel coronavirus (2019-nCoV) who were transferred to Jinyintan Hospital, an adult infectious disease hospital admitting
This week (25 July) the Genomics of Drug Sensitivity in Cancer project has released the results of four years of intense data gathering and exploration which will power
Around one in six New Zealand adults have tried e-cigarettes but only 2 percent are using them currently, a national survey has found. However, the research led by
A new University of California, Irvine-led pilot study finds, on average, Waze “crash alerts” occur two minutes and 41 seconds prior to their corresponding California Highway Patrol (CHP)-reported
Specific angles and sharpness of brain waves seen in unfiltered raw data from scalp electroencephalograms have been tied to Parkinson’s disease. Reporting in the online journal eNeuro, researchers
Your personal identity may fall at the mercy of sophisticated hackers on many websites, but when it comes to health data breaches, hospitals, doctors offices and even insurance
TUESDAY, Oct. 16, 2018 — Dozens of scientific papers from the laboratory of well-known heart researcher Piero Anversa contain fraudulent data, according to a Harvard Medical School internal
Geneva, Switzerland and Boston, MA – October 9, 2018 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a Swiss clinical-stage biopharmaceutical company focused on the development and commercialization
Copenhagen, September 28, 2018 – Orphazyme A/S, a biopharmaceutical company dedicated to developing treatments for patients living with rare diseases, today announced encouraging top-line results for its clinical
We and our partners use cookies on this site to improve our service, perform analytics, personalize advertising, measure advertising performance, and remember website preferences.Ok